344 related articles for article (PubMed ID: 34389338)
1. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts.
Xia B; Yang M; Nguyen LH; He Q; Zhen J; Yu Y; Di M; Qin X; Lu K; Kuo ZC; He Y; Zhang C; Meng W; Yuan J
Gastroenterology; 2021 Dec; 161(6):1842-1852.e10. PubMed ID: 34389338
[TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitor Use Before and After a Diagnosis of Inflammatory Bowel Disease.
Singh N; Nugent Z; Singh H; Shaffer SR; Bernstein CN
Inflamm Bowel Dis; 2023 Dec; 29(12):1871-1878. PubMed ID: 36790051
[TBL] [Abstract][Full Text] [Related]
3. Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.
Varma S; Trudeau SJ; Li J; Freedberg DE
Inflamm Bowel Dis; 2024 Jan; 30(1):38-44. PubMed ID: 36917215
[TBL] [Abstract][Full Text] [Related]
4. Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts.
He Q; Huang C; Qin X; Yu Y; Tang D; Huang J; Kuo ZC; Ling Y; Mao D; Xia B; Li W; Lu K; Yang M; He Y; Meng W; Yuan J; Pan Y
Int J Cancer; 2023 Sep; 153(5):942-949. PubMed ID: 37232081
[TBL] [Abstract][Full Text] [Related]
5. Gastric Acid Suppression Is Associated with an Increased Risk of Adverse Outcomes in Inflammatory Bowel Disease.
Shah R; Richardson P; Yu H; Kramer J; Hou JK
Digestion; 2017; 95(3):188-193. PubMed ID: 28288458
[TBL] [Abstract][Full Text] [Related]
6. Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis.
Lo CH; Lochhead P; Khalili H; Song M; Tabung FK; Burke KE; Richter JM; Giovannucci EL; Chan AT; Ananthakrishnan AN
Gastroenterology; 2020 Sep; 159(3):873-883.e1. PubMed ID: 32389666
[TBL] [Abstract][Full Text] [Related]
7. Intake of Ultra-processed Foods Is Associated with an Increased Risk of Crohn's Disease: A Cross-sectional and Prospective Analysis of 187 154 Participants in the UK Biobank.
Chen J; Wellens J; Kalla R; Fu T; Deng M; Zhang H; Yuan S; Wang X; Theodoratou E; Li X; Satsangi J
J Crohns Colitis; 2023 Apr; 17(4):535-552. PubMed ID: 36305857
[TBL] [Abstract][Full Text] [Related]
8. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
9. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts.
Khalili H; Ananthakrishnan AN; Konijeti GG; Liao X; Higuchi LM; Fuchs CS; Spiegelman D; Richter JM; Korzenik JR; Chan AT
BMJ; 2013 Nov; 347():f6633. PubMed ID: 24231178
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of pneumonia among patients with inflammatory bowel disease.
Long MD; Martin C; Sandler RS; Kappelman MD
Am J Gastroenterol; 2013 Feb; 108(2):240-8. PubMed ID: 23295276
[TBL] [Abstract][Full Text] [Related]
11. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies.
Yuan J; He Q; Nguyen LH; Wong MCS; Huang J; Yu Y; Xia B; Tang Y; He Y; Zhang C
Gut; 2021 Jun; 70(6):1070-1077. PubMed ID: 32989021
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank.
Wu S; Xie S; Yuan C; Yang Z; Liu S; Zhang Q; Sun F; Wu J; Zhan S; Zhu S; Zhang S
Inflamm Bowel Dis; 2023 Mar; 29(3):384-395. PubMed ID: 35639937
[TBL] [Abstract][Full Text] [Related]
13. Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study.
Chen J; Dan L; Tu X; Sun Y; Deng M; Chen X; Hesketh T; Li R; Wang X; Li X
Hepatol Int; 2023 Feb; 17(1):202-214. PubMed ID: 36194337
[TBL] [Abstract][Full Text] [Related]
14. Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study.
Khalili H; Burke KE; Roelstraete B; Sachs MC; Olén O; Ludvigsson JF
Gastroenterology; 2020 May; 158(6):1574-1583.e2. PubMed ID: 31926169
[TBL] [Abstract][Full Text] [Related]
15. Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease.
Choden T; Zhang H; Sakuraba A
Ann Med; 2023 Dec; 55(1):2198775. PubMed ID: 37070427
[TBL] [Abstract][Full Text] [Related]
16. Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study.
Yuan J; Zhang C; Sparks JA; Malspeis S; Tsoi KK; Kim JH; Fisher BA; Gao F; Sumerlin T; Liu Y; Liu Y; Pan Y; He Y; Sung JJY
Aliment Pharmacol Ther; 2020 Aug; 52(3):449-458. PubMed ID: 32598046
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study.
Onwuzo S; Boustany A; Khaled Abou Zeid H; Hitawala A; Almomani A; Onwuzo C; Lawrence F; Mascarenhas Monteiro J; Ndubueze C; Asaad I
Cureus; 2023 Jan; 15(1):e34088. PubMed ID: 36843811
[TBL] [Abstract][Full Text] [Related]
18. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
[TBL] [Abstract][Full Text] [Related]
19. Ulcerative colitis increases risk of hypertension in a UK biobank cohort study.
He J; Zhang S; Qiu Y; Liu F; Liu Z; Tan J; Hu F; Wu X; Wang Y; Zhou L; Hu S; Chen M; Liao X; Zhuang X; Mao R
United European Gastroenterol J; 2023 Feb; 11(1):19-30. PubMed ID: 36507867
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease.
Khalili H; Higuchi LM; Ananthakrishnan AN; Richter JM; Feskanich D; Fuchs CS; Chan AT
Gut; 2013 Aug; 62(8):1153-9. PubMed ID: 22619368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
